Status:

ACTIVE_NOT_RECRUITING

Effect of Dapagliflozin on the Recurrence of Atrial Tachyarrhythmia in Patients Undergoing Catheter Ablation of Atrial Fibrillation

Lead Sponsor:

Chang Gung Memorial Hospital

Conditions:

Atrial Fibrillation Recurrent

Catheter Ablation

Eligibility:

All Genders

20+ years

Phase:

PHASE2

PHASE3

Brief Summary

The goal of this clinical trial is to test the effect of Dapagliflozin on the Recurrence of Atrial Tachyarrhythmia in Patients Undergoing Catheter Ablation of Atrial Fibrillation. The main questions i...

Detailed Description

This trial is the third phase of random allocation and non-blind trial. It is divided into study group and control group. The study group is Dapagliflozin therapy, and the treatment period is three mo...

Eligibility Criteria

Inclusion

  • Ability to give written informed consent
  • Men and women age \>= 20 years.
  • Paroxysmal, persistent or long-standing persistent atrial fibrillation
  • eGFR \>= 25 ml/min/1.73 m2

Exclusion

  • Receiving therapy with a sodium-glucose cotransporter 2 (SGLT2) inhibitor prior to randomization, or intolerance to an SGLT2 inhibitor.
  • Type 1 diabetes mellitus
  • Acute coronary syndrome, coronary revascularization (percutaneous coronary intervention or Coronary artery bypass grafting), ablation of atrial flutter/fibrillation, ischemic stroke, and transient ischemic attack within 12 weeks prior to randomization
  • Active malignancy
  • Women of child-bearing potential who have a positive pregnancy test at randomization or who are breast-feeding
  • A life expectancy of fewer than 2 years due to any non-cardiovascular condition, based on the investigator's clinical judgment
  • Expected surgery for structural heart disease, and secondary atrial fibrillation (due to cardiac surgery, infection, or hyperthyroidism)

Key Trial Info

Start Date :

December 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 30 2026

Estimated Enrollment :

196 Patients enrolled

Trial Details

Trial ID

NCT06111443

Start Date

December 1 2023

End Date

November 30 2026

Last Update

December 21 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kaoshiung Chang Gung Memorial

Kaohsiung City, Taiwan